114 related articles for article (PubMed ID: 30932882)
41. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
[TBL] [Abstract][Full Text] [Related]
42. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
43. ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis.
Braganhol E; de Andrade GPB; Santos GT; Stefani MA
Purinergic Signal; 2024 Jun; 20(3):285-289. PubMed ID: 37402102
[TBL] [Abstract][Full Text] [Related]
44. Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Kawamura M; Kawamoto A; Okugawa Y; Saigusa S; Hiro J; Inoue Y; Mohri Y; Goel A; Kusunoki M
Clin Cancer Res; 2014 Dec; 20(23):6175-86. PubMed ID: 25294915
[TBL] [Abstract][Full Text] [Related]
45. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
46. NT5E mutations that cause human disease are associated with intracellular mistrafficking of NT5E protein.
Fausther M; Lavoie EG; Goree JR; Baldini G; Dranoff JA
PLoS One; 2014; 9(6):e98568. PubMed ID: 24887587
[TBL] [Abstract][Full Text] [Related]
47. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
49. Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer.
Vocka M; Langer D; Fryba V; Petrtyl J; Hanus T; Kalousova M; Zima T; Petruzelka L
Cancer Biomark; 2018; 21(4):869-874. PubMed ID: 29400662
[TBL] [Abstract][Full Text] [Related]
50. NT5E gene and CD38 protein as potential prognostic biomarkers for childhood B-acute lymphoblastic leukemia.
da Silva Nunes VB; Dias CK; De Bastiani MA; Farias MG; Spagnol F; Alegretti AP; Daudt LE; Michalowski MB; Battastini AMO; Paz AA; Figueiró F
Purinergic Signal; 2022 Jun; 18(2):211-222. PubMed ID: 35235138
[TBL] [Abstract][Full Text] [Related]
51. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
52. Preoperative serum placenta growth factor level as a new marker for stage II or III colorectal cancer patients.
Kemık O; Sarbay Kemık A; Sümer A; Purısa S; Tükenmez B; Tüzün S
Turk J Gastroenterol; 2012 Apr; 23(2):104-9. PubMed ID: 22706737
[TBL] [Abstract][Full Text] [Related]
53. [Expression of MACC1 protein in colorectal cancer and its relationship with clinicopathological characteristics].
Xu L; Xuan Z; Lin G; Qiu H; Xiao Y; Wu B
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):1032-5. PubMed ID: 26499151
[TBL] [Abstract][Full Text] [Related]
54. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
[TBL] [Abstract][Full Text] [Related]
55. Clinical and prognostic significance of Arl4c expression in colorectal cancer.
Chen X; Su Z; Wang S; Xu H
Cancer Biomark; 2016; 16(2):253-7. PubMed ID: 26756615
[TBL] [Abstract][Full Text] [Related]
56. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
57. The prognostic value of p53 positive in colorectal cancer: A retrospective cohort study.
Wang P; Liang J; Wang Z; Hou H; Shi L; Zhou Z
Tumour Biol; 2017 May; 39(5):1010428317703651. PubMed ID: 28468582
[TBL] [Abstract][Full Text] [Related]
58. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Anticancer Res; 2014 Jul; 34(7):3753-8. PubMed ID: 24982398
[TBL] [Abstract][Full Text] [Related]
59. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
